SCHEMBL2333769

SCHEMBL2333769

COC(=O)/C(C)=C/N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2216606 1.00
SCHEMBL28811422 0.82 BRD4 (0.36)
SCHEMBL19687170 0.80 ALDH1A1 (0.37)
SCHEMBL12957658 0.78
SCHEMBL15641383 0.78
SCHEMBL2971024 0.77
Ethylenediamine SCHEMBL17453352 0.77 ALDH1A1 (0.39)
Ethylamine SCHEMBL28816778 0.77 ALDH1A1 (0.39)
SCHEMBL25246818 0.77 ALDH1A1 (0.48)
SCHEMBL1821223 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0326389-B1 Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES (JP) 1996-09-11 EP claimed
US-4935516-A Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES, LTD. (JP) 1990-06-19 US claimed
EP-0326389-A2 Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES, LTD. (JP) 1989-08-02 EP claimed
US-20210113534-A1 COMPOUNDS THE UNIVERSITY OF SHEFFIELD (GB) 2021-04-22 US disclosed
WO-2020112937-A1 TYK2 INHIBITORS AND USES THEREOF NIMBUS LAKSHMI, INC. (US) 2020-06-04 WO disclosed
EP-2533772-A2 METHODS AND COMPOSITIONS FOR WOUND HEALING Wound Engineering LLC (US) 2012-12-19 EP disclosed
WO-2011100425-A2 METHODS AND COMPOSITIONS FOR WOUND HEALING WOUND ENGINEERING LLC (US) 2011-08-18 WO disclosed
EP-2262474-A2 METHODS AND COMPOSITIONS FOR WOUND HEALING Mcanulty, Jonathan (US) 2010-12-22 EP disclosed
WO-2009097508-A2 METHODS AND COMPOSITIONS FOR WOUND HEALING MCANULTY, JONATHAN (US) 2009-08-06 WO disclosed
EP-1853294-A2 ANTI-ANGIOGENIC COMPOUNDS Covx Technologies Ireland Limited (IE) 2007-11-14 EP disclosed
WO-2006094269-A2 ANTI-ANGIOGENIC COMPOUNDS COVX TECHNOLOGIES IRELAND LIMITED (IE) 2006-09-08 WO disclosed
WO-2006076471-A2 BNP CONJUGATES AND METHODS OF USE NOBEX CORPORATION (US) 2006-07-20 WO disclosed
WO-2002057463-A2 SWAP/COUNTER SELECTION; A RAPID CLONING METHOD GALAPAGOS GENOMICS B.V. (NL) 2002-07-25 WO disclosed
EP-0326389-B1 Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES (JP) 1996-09-11 EP disclosed
US-4935516-A Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES, LTD. (JP) 1990-06-19 US disclosed
EP-0326389-A2 Process for preparing 4-hydroxypyrimidine UBE INDUSTRIES, LTD. (JP) 1989-08-02 EP disclosed